0001576885-24-000036.txt : 20240201
0001576885-24-000036.hdr.sgml : 20240201
20240201170207
ACCESSION NUMBER: 0001576885-24-000036
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240201
FILED AS OF DATE: 20240201
DATE AS OF CHANGE: 20240201
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Doherty James J.
CENTRAL INDEX KEY: 0002009718
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40551
FILM NUMBER: 24587782
MAIL ADDRESS:
STREET 1: C/O ACUMEN PHARMACEUTICALS, INC.
STREET 2: 427 PARK ST.
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Acumen Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001576885
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 364108129
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 427 PARK ST.
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
BUSINESS PHONE: 925-368-8508
MAIL ADDRESS:
STREET 1: 427 PARK ST.
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
4
1
wk-form4_1706824917.xml
FORM 4
X0508
4
2024-02-01
0
0001576885
Acumen Pharmaceuticals, Inc.
ABOS
0002009718
Doherty James J.
C/O ACUMEN PHARMACEUTICALS, INC.
427 PARK STREET
CHARLOTTESVILLE
VA
22902
0
1
0
0
President and CDO
0
Employee Stock Option (right to buy)
3.11
2024-02-01
4
A
0
601000
0
A
2034-02-01
Common Stock
601000
601000
D
Twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on February 1, 2025, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest and become exercisable each month thereafter, subject to Reporting Person continuing to provide service through each such date.
/s/ Derek Meisner, Attorney-in-Fact
2024-02-01